NCT05864729

Brief Summary

The present study evaluates skin microvascular reactivity and coronary physiology in the same coronary artery disease (CAD) patients. This study is expected to find associations between systemic microvascular reactivity, measured non-invasively at the skin surface, and coronary reserve evaluated by the invasive angiographic method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

2.5 years

First QC Date

May 8, 2023

Last Update Submit

March 24, 2024

Conditions

Keywords

endothelial functioncoronary flow reservelaser speckle

Outcome Measures

Primary Outcomes (1)

  • Assessment by fractional flow reserve (FFR) and contrast fractional flow reserve (cFFR).

    Physiological coronary artery obstruction assessment through FFR and cFFR. For FFR and cFFR measurement, a 0.014FR guidewire will be advanced distal to the lesion, with baseline and hyperemic (after adenosine or contrast administration) vascular pressure measurements, with two-minute interval between each measurement.

    day 1 visit to the hemodynamic laboratory

Secondary Outcomes (1)

  • Systemic microvascular reactivity

    day 1 visit to the hemodynamic laboratory

Interventions

Hemodynamic invasive study employing FFR (after intracoronary adenosine administration) and cFFR (after intracoronary lopamidol contrast media administration) measurements of hyperemic intravascular pressure.

Also known as: Evaluation of systemic skin microvascular endothelial function

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with intermediate obstructive coronary artery disease (40-80% lumen obstruction of epicardial vessels or 30-60% obstruction of left main coronary artery).

You may not qualify if:

  • ST elevation myocardial infarction in the first 72 hours of evolution.
  • Allergy to contrast media or adenosine
  • Asthma or chronic obstructive pulmonary artery disease diagnosis
  • Ongoing acute coronary syndrome
  • Systolic blood pressure under 90mmHg
  • Baseline arrhythmias or advanced atrioventricular blockade
  • Advanced arterial calcification
  • Renal failure (defined as serum creatinine above 1.5mg/dl)
  • Saphenous graft or mammary artery graft anastomosis stenosis
  • Severe left ventricular systolic dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Cardiology

Rio de Janeiro, 21040-360, Brazil

Location

MeSH Terms

Conditions

Myocardial Ischemia

Interventions

Coronary Angiography

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisAngiographyRadiographyDiagnostic Techniques, CardiovascularHeart Function Tests

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 8, 2023

First Posted

May 18, 2023

Study Start

June 1, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

March 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations